348 related articles for article (PubMed ID: 21265828)
1. The utility of animal models to evaluate novel anti-obesity agents.
Vickers SP; Jackson HC; Cheetham SC
Br J Pharmacol; 2011 Oct; 164(4):1248-62. PubMed ID: 21265828
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of weight-reducing drugs in people with hypertension.
Siebenhofer A; Jeitler K; Horvath K; Berghold A; Posch N; Meschik J; Semlitsch T
Cochrane Database Syst Rev; 2016 Mar; 3():CD007654. PubMed ID: 26934640
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of appetite suppression: implication for the treatment of obesity.
Halford JC
Curr Drug Targets; 2001 Dec; 2(4):353-70. PubMed ID: 11732637
[TBL] [Abstract][Full Text] [Related]
5. Long-term pharmacotherapy for obesity and overweight.
Padwal R; Li SK; Lau DC
Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacotherapy for obesity: current drugs and those in advanced development.
Halford JC
Curr Drug Targets; 2004 Oct; 5(7):637-46. PubMed ID: 15473253
[TBL] [Abstract][Full Text] [Related]
7. Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite.
Rodgers RJ; Holch P; Tallett AJ
Pharmacol Biochem Behav; 2010 Nov; 97(1):3-14. PubMed ID: 20214921
[TBL] [Abstract][Full Text] [Related]
8. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].
Richter WO
MMW Fortschr Med; 1999 Dec; 141(49-50):32-6. PubMed ID: 10726144
[TBL] [Abstract][Full Text] [Related]
9. Drug strategies for the treatment of obesity.
Alemany M; Remesar X; Fernández-López JA
IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
[TBL] [Abstract][Full Text] [Related]
10. [Drug treatment of obesity].
Svendsen OL; Toubro S; Breum L; Bruun JM; Astrup AV
Ugeskr Laeger; 2006 Jan; 168(2):163-7. PubMed ID: 16403342
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents.
García Díaz E; Martín Folgueras T
Nutr Hosp; 2011; 26(3):451-7. PubMed ID: 21892560
[TBL] [Abstract][Full Text] [Related]
12. Long-term pharmacotherapy for obesity.
Klein S
Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
[TBL] [Abstract][Full Text] [Related]
13. Obesity: pathophysiology and clinical management.
Gurevich-Panigrahi T; Panigrahi S; Wiechec E; Los M
Curr Med Chem; 2009; 16(4):506-21. PubMed ID: 19199918
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for weight management.
Palatty PL; Saldanha E
J Assoc Physicians India; 2012 Mar; 60():34-40, 45. PubMed ID: 22799113
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacotherapy in the treatment of obesity].
Hamann A
MMW Fortschr Med; 2006 Mar; 148(9):36-8. PubMed ID: 16566392
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological approaches to intervention.
Guy-Grand B
Int J Obes Relat Metab Disord; 1997 Mar; 21 Suppl 1():S22-4. PubMed ID: 9130037
[TBL] [Abstract][Full Text] [Related]
17. [Weight loss via drug therapy].
Wirth A
Internist (Berl); 2003 Mar; 44(3):359-62, 363-6. PubMed ID: 12731423
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy for obesity.
Halford JC
Appetite; 2006 Jan; 46(1):6-10. PubMed ID: 16229924
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacotherapy of obesity].
Tripp B; Ludvik B
Wien Med Wochenschr; 2004 Jul; 154(13-14):320-8. PubMed ID: 15368953
[TBL] [Abstract][Full Text] [Related]
20. Obesity and cardiovascular physiology: impact of some pharmacological agents.
Chaput JP; Bérubé-Parent S; Tremblay A
Curr Vasc Pharmacol; 2005 Apr; 3(2):185-93. PubMed ID: 15853638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
